138 related articles for article (PubMed ID: 28485090)
1. Risk of stroke in prescription and other amphetamine-type stimulants use: A systematic review.
Indave BI; Sordo L; Bravo MJ; Sarasa-Renedo A; Fernández-Balbuena S; De la Fuente L; Sonego M; Barrio G
Drug Alcohol Rev; 2018 Jan; 37(1):56-69. PubMed ID: 28485090
[TBL] [Abstract][Full Text] [Related]
2. Amphetamine-type stimulants and HIV infection among men who have sex with men: implications on HIV research and prevention from a systematic review and meta-analysis.
Vu NT; Maher L; Zablotska I
J Int AIDS Soc; 2015; 18(1):19273. PubMed ID: 25609214
[TBL] [Abstract][Full Text] [Related]
3. Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review.
Westover AN; Halm EA
BMC Cardiovasc Disord; 2012 Jun; 12():41. PubMed ID: 22682429
[TBL] [Abstract][Full Text] [Related]
4. Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of randomized placebo-controlled trials.
Sharafi H; Bakouni H; McAnulty C; Drouin S; Coronado-Montoya S; Bahremand A; Bach P; Ezard N; Le Foll B; Schütz CG; Siefried KJ; Tardelli VS; Ziegler D; Jutras-Aswad D
Addiction; 2024 Feb; 119(2):211-224. PubMed ID: 37880829
[TBL] [Abstract][Full Text] [Related]
5. Look west for Australian evidence of the relationship between amphetamine-type stimulant prescribing and meth/amphetamine use.
Whitely M; Allsop S
Drug Alcohol Rev; 2020 Jul; 39(5):519-524. PubMed ID: 32314469
[TBL] [Abstract][Full Text] [Related]
6. Use of amphetamine-type stimulants in the Islamic Republic of Iran, 2004-2015: a review.
Shadloo B; Amin-Esmaeili M; Haft-Baradaran M; Noroozi A; Ghorban-Jahromi R; Rahimi-Movaghar A
East Mediterr Health J; 2017 May; 23(3):245-256. PubMed ID: 28493273
[TBL] [Abstract][Full Text] [Related]
7. Amphetamine-type stimulant use and self-harm: protocol for a systematic review of observational studies.
Cumming C; Armstrong G; Borschmann R; Foulds JA; Newton-Howes G; McKetin R; Vallesi S; Preen D; Young J
BMJ Open; 2022 Jan; 12(1):e057029. PubMed ID: 35074824
[TBL] [Abstract][Full Text] [Related]
8. Social support and amphetamine-type stimulant use among female sex workers in China.
Zhao Q; Mao Y; Li X; Zhou Y; Shen Z
AIDS Care; 2017 Oct; 29(10):1324-1330. PubMed ID: 28514866
[TBL] [Abstract][Full Text] [Related]
9. Ice in the Outback: the epidemiology of amphetamine-type stimulant-related hospital admissions and presentations to the emergency department in Hedland, Western Australia.
Monahan C; Coleman M
Australas Psychiatry; 2018 Aug; 26(4):417-421. PubMed ID: 29533079
[TBL] [Abstract][Full Text] [Related]
10. Exposure to Amphetamines Leads to Development of Amphetamine Type Stimulants Associated Cardiomyopathy (ATSAC).
Jafari Giv M
Cardiovasc Toxicol; 2017 Jan; 17(1):13-24. PubMed ID: 27663745
[TBL] [Abstract][Full Text] [Related]
11. Amphetamine-Type Stimulant Dependence and Association with Concurrent Use of Cocaine, Alcohol, and Cannabis: A Cross-Sectional Study.
Berndt S; Rosenkranz M; Martens MS; Verthein U
Eur Addict Res; 2022; 28(2):113-121. PubMed ID: 34788752
[TBL] [Abstract][Full Text] [Related]
12. Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.
Tardelli VS; Bisaga A; Arcadepani FB; Gerra G; Levin FR; Fidalgo TM
Psychopharmacology (Berl); 2020 Aug; 237(8):2233-2255. PubMed ID: 32601988
[TBL] [Abstract][Full Text] [Related]
13. Individual, Social, and Environmental Factors Associated with Different Patterns of Stimulant Use: A Cross-Sectional Study from Five European Countries.
Rosenkranz M; O'Donnell A; Martens MS; Zurhold H; Degkwitz P; Liebregts N; Barták M; Rowicka M; Verthein U
Eur Addict Res; 2023; 29(3):182-193. PubMed ID: 37166303
[TBL] [Abstract][Full Text] [Related]
14. Nondependent stimulant users of cocaine and prescription amphetamines show verbal learning and memory deficits.
Reske M; Eidt CA; Delis DC; Paulus MP
Biol Psychiatry; 2010 Oct; 68(8):762-9. PubMed ID: 20605137
[TBL] [Abstract][Full Text] [Related]
15. Amphetamine-type stimulant use among men who have sex with men (MSM) in Vietnam: Results from a socio-ecological, community-based study.
Vu NT; Holt M; Phan HT; Le HT; La LT; Tran GM; Doan TT; Nguyen TN; de Wit J
Drug Alcohol Depend; 2016 Jan; 158():110-7. PubMed ID: 26656138
[TBL] [Abstract][Full Text] [Related]
16. Using life course charts to assess and compare trajectories of amphetamine type stimulant consumption in different user groups: a cross-sectional study.
Martens MS; Zurhold H; Rosenkranz M; O'Donnell A; Addison M; Spencer L; McGovern W; Gabrhelík R; Petruželka B; Rowicka M; Liebregts N; Degkwitz P; Kaner E; Verthein U
Harm Reduct J; 2020 Jan; 17(1):8. PubMed ID: 31931819
[TBL] [Abstract][Full Text] [Related]
17. Cocaine use and risk of stroke: a systematic review.
Sordo L; Indave BI; Barrio G; Degenhardt L; de la Fuente L; Bravo MJ
Drug Alcohol Depend; 2014 Sep; 142():1-13. PubMed ID: 25066468
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.
Hennissen L; Bakker MJ; Banaschewski T; Carucci S; Coghill D; Danckaerts M; Dittmann RW; Hollis C; Kovshoff H; McCarthy S; Nagy P; Sonuga-Barke E; Wong IC; Zuddas A; Rosenthal E; Buitelaar JK;
CNS Drugs; 2017 Mar; 31(3):199-215. PubMed ID: 28236285
[TBL] [Abstract][Full Text] [Related]
19. Amphetamine-type stimulant use and the risk of injury or death as a result of a road-traffic accident: A systematic review of observational studies.
Hayley AC; Downey LA; Shiferaw B; Stough C
Eur Neuropsychopharmacol; 2016 Jun; 26(6):901-22. PubMed ID: 27006144
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China.
Zhang Y; Lu C; Zhang J; Hu L; Song H; Li J; Kang L
Addict Behav; 2013 Jan; 38(1):1424-30. PubMed ID: 23006246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
